相关实验视频

Updated: Jun 1, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.2K

人性化抗CD11d单克隆抗体适用于基础研究和治疗应用

Eoin N Blythe1, Christy Barreira2, Corby Fink1

  • 1Department of Microbiology & Immunology and Robarts Research Institute, University of Western Ontario, London, Ontario N6A 5B7, Canada.

Antibody therapeutics
|January 22, 2025
PubMed
概括

人性化抗CD11d抗体被开发用于向CD11d/CD18整合素治疗炎症疾病. 这些抗体在神经创伤模型中显示出治疗潜力,并为研究CD11d生物学提供了新的工具.

关键词:
在CD11dCD18中,可以看到CD11dCD18.整体的整体是整体的这是一种单克隆抗体.治疗性抗体治疗性抗体

更多相关视频

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.2K
Isolation and Characterization of Neutrophils with Anti-Tumor Properties10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

24.8K

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K